echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Levofloxacin API, a subsidiary of Jingxin Pharmaceuticals, obtained CEP certificate

    Levofloxacin API, a subsidiary of Jingxin Pharmaceuticals, obtained CEP certificate

    • Last Update: 2021-06-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the 18th, Jingxin Pharmaceutical announced that its wholly-owned subsidiary, Shangyu Jingxin, received the European Pharmacopoeia Certificate of Applicability for Levofloxacin API issued by the European Medicines Quality Administration
    .

    Levofloxacin is one of the quinolone drugs with broad-spectrum antibacterial effect.
    It is suitable for respiratory infections, urinary system infections, reproductive system infections, skin and soft tissue infections, intestinal infections and other infections caused by sensitive bacteria
    .

    According to statistics, the global use of levofloxacin API will be about 718 tons in 2020, of which about 93 tons will be used in the European market
    .


    (Data comes from NEWPORT)


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.